The GOP tax plan, BioMarin’s gene therapy and a Twist on DNA — Day 2 of the JPM conference – San Francisco Business Times
San Francisco Business Times |
The GOP tax plan, BioMarin’s gene therapy and a Twist on DNA — Day 2 of the JPM conference
San Francisco Business Times Around last year’s JPM, President-elect Donald Trump unleashed a tweet that took a swipe at the drug-development industry, sent stocks down and caused some grumbles amid a mostly upbeat conference. This year? It seems drug companies couldn’t love the … |
Sickle Cell Anemia News |
Bluebird Bio Presents Positive Early Results of Gene Therapy LentiGlobin for Sickle Cell Disease
Sickle Cell Anemia News Participants with severe SCD were split into three groups – A, B and C. Patients in group A received the treatment according to the trial’s original protocol: After cells are collected from the bone marrow, they are transduced with the LentiGlobin … |
|
New biomarkers predict outcome of cancer immunotherapy
EurekAlert (press release) Nowadays, melanoma and lung cancer can be combatted effectively through immunotherapy, which makes use of the immune system’s normal function of regularly examining the body’s tissue for pathogens and damages. Specific inhibitors are used to activate … |